James Chen has a simple test for whether a billionaire is doing philanthropy right: is the capital taking real risk, or just buying a nameplate?
Writing in Fortune on August 9, 2026, Chen — founder of the Clearly campaign and chairman of The Chen Yet-Sen Family Foundation — makes the case that the philanthropic class is squandering its most valuable asset: the freedom to fail without answering to taxpayers or shareholders.
'Donating, as many do, to check a box or as a reputation-building exercise accomplishes very little,' Chen writes. 'It undermines the true superpower of philanthropy: its unique agency to serve as early-stage risk capital for radical, systemic innovation.'
The Rwanda proof of concept
Chen's argument is grounded in two decades of his own work. Twenty years ago he lobbied the World Bank for two years to back adjustable-power lenses for low-income countries. The answer was no. Rather than walking away, he launched Vision for a Nation, trained 2,700 local nurses, and conducted screenings across all 15,000 villages in Rwanda. The result: Rwanda became, according to Chen, the first country in the world with universal access to affordable vision correction.
The lesson he draws is precise. Private philanthropists, unlike governments, can absorb the cost of a failed bet entirely themselves. When the bet pays off, the benefits scale globally — at no further cost to the public purse.
Turning health into an economic argument
Chen did not stop at Rwanda. To move global institutions that still treated vision as a low priority, he commissioned randomized controlled trials. A trial among tea-pickers in Assam, India, found that workers given glasses recorded a 21.7% increase in daily productivity. That single figure reframed eyecare from a health charity line item into a measurable economic growth driver.
The evidence base, Chen says, led the United Nations to pass a 2021 resolution committing all 193 member states to eyecare for all by 2030.
The $124 trillion moment
Chen's op-ed lands at a specific inflection point. He cites projections that the great wealth transfer will hand upward of $124 trillion to a new generation by 2048, alongside wealth being generated by tech founders and AI investors. His call to action is direct: that generation already has the entrepreneurial drive and risk tolerance that philanthropy needs. The question is whether it will bring those instincts into giving before the moment passes.
CEO Times take
Chen's framework is, at its core, a free-market argument dressed in philanthropic language — and it is stronger for it. Private capital, unconstrained by electoral cycles or shareholder quarterly reports, is structurally better positioned than any government program to absorb early-stage risk on hard problems. The 21.7% productivity gain in Assam is not a feel-good statistic; it is the kind of return on investment that justifies the capital allocation.
The broader point deserves amplification: when billionaires deploy capital with genuine risk tolerance, they de-risk problems for the institutions — including governments — that eventually have to fund solutions at scale. That is leverage. The alternative — eponymous hospital wings and alma mater donations — is consumption masquerading as investment. The market for social impact, like every other market, rewards those who take the bet early.
